Practical management of the intersex infant

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 1, 2005, Pages 3-23

  Brown, Justin ^a   Warne, Garry ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Androgen insensitivity; Congenital adrenal hyperplasia; Genital ambiguity; Gonadal dysgenesis; Intersex; Newborn

Indexed keywords

GROWTH HORMONE; STEROID 21 MONOOXYGENASE; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE 2; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; UNCLASSIFIED DRUG;

ALGORITHM; ANDROGEN INSENSITIVITY SYNDROME; CLINICAL EXAMINATION; CONGENITAL ADRENAL HYPERPLASIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME DEFICIENCY; GENITAL SYSTEM; GONAD; GONADAL DYSGENESIS; HERMAPHRODITISM; HUMAN; INFANT; KARYOTYPE 46,XX; KARYOTYPE 46,XY; MUELLERIAN DUCT; PALPATION; PHYSICAL EXAMINATION; PRENATAL DEVELOPMENT; REVIEW; SEX DETERMINATION; SEXUAL DEVELOPMENT; TEAMWORK; UTERUS; VIRILIZATION;

EID: 13644266468     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.1.3     Document Type: Review

References (85)

1. Hamerton JL, Canning N, Ray M, Smith S. A cytogenetic survey of 14,069 newborn infants. Clin Genet 1975; 8: 223-243.
2. Jost A. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Rec Prog Horm Res 1953; 8: 379-418.
3. Ahmed SF, Hughes IA. The genetics of male under-masculinisation. Clin Endocrinol 2002; 56: 1-18.
4. Hughes IA. Intersex. BJU Int 2002; 90: 769-776.
5. MacLoughlin DT, Donahoe PK. Sex determination and differentiation. N Engl J Med 2004; 350: 367-8.
6. Pinsky L, Erikson RP, Schimke RN. The embryology of normal gonadal and genital development. In: Genetic Disorders of Human Development. Oxford: Oxford University Press, 1999; 3-10.
7. Hutson JM, Beasley SW. Descent of the Testis. London: Edward Arnold, 1992; 1-187.
8. Kubota Y, Nef S, Farmer PJ, Temelcos C, Parada LF, Hutson JM. Leydig insulin-like hormone, gubernacular development and testicular descent. J Urol 2001; 165: 1673-1675.
9. Kubota Y, Temelcos C, Bathgate RA Smith KJ, Scott D, Zhao C, Hutson JM. The role of Ins13, testosterone, Müllerian inhibiting substance and relaxin in rat gubernacular growth. Mol Hum Reprod 2002; 8: 900-905.
10. Canto P, Escudero I, Soderlund D, Nishimura E, Carranza-Lira S, Gutierrez J, Nava A, Mendez JP. A novel mutation of the Ins13 gene in patients with cryptorchidism. J Hum Genet 2003; 48: 86-90.
11. Ferlin A, Simonato M, Bartoloni L, Rizzo G, Bettella A, Dottorini T, Dallapiccola B, Foresta, C. The INSL3-LGR8/GREAT ligand receptor pair in human cryptorchidism. J Clin Endocrinol Metab 2003; 88: 4273-4279.
12. Lim HN, Hughes IA, Hawkins JR. Clinical and molecular evidence of the role of androgens in testicular descent. Mol Cell Endocrinol 2001; 185: 43-50.
13. Hrabovsky Z, Farmer PJ, Hutson JM. Undescended testis is accompanied by calcitonin gene related peptide accumulation within the sensory nucleus of the genito-femoral nerve in trans-scrotal rats. J Urol 2001; 165: 1015-1018.
14. Grumbach MM, Hughes IA, Conte FA. Disorders of sex differentiation. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Textbook of Endocrinology, 10th Ed. Philadelphia, PA: WB Saunders, 2003; 934-935.
15. Pajkrt E, Chitty LS. Prenatal gender determination and the diagnosis of genital anomalies. BJU Int 2004; 93 (Suppl 3): 12-19.
16. Malone PS. Bladder exstrophy and epispadias complex. In: Freeman NV, Burge DM, Griffiths M, Malone PSJ, eds. Surgery of the Newborn. London: Churchill Livingstone, 1994; 755-765.
17. Monfort GJ. Male and female genital anomalies. In: Freeman NV, Burge DM, Griffiths M, Malone PSJ, eds. Surgery of the Newborn. London: Churchill Livingstone 1994; 793-802.
18. Freeman NV. Anorectal malformations. In: Freeman NV, Burge DM, Griffiths M, Malone PSJ, eds. Surgery of the Newborn. London: Churchill Livingstone 1994; 171-99.
19. Prader A. Der Genitalbeifund beim Pseudohermaphroditismus feminus des kongenitalen, adrenogenitalen Syndroms. Morphologie, Haeufigkeit, Entwicklung und Vererbung der verscheidenen Genitalformen. Helv Paediatr Acta 1954; 9: 231.
20. Ahmed SF, Khawaja O, Hughes, IA. Clinical and gender assignment in cases of male undermasculinisation. Br J Urol 2000; 85: 120-124.
21. Schonfeld WA, Beebe GW. Normal growth and variation in the male genitalia from birth to maturity. J Urol 1942; 48: 759-777.
22. Feldman KW, Smith DW. Fetal phallic growth and penile standards for newborn male infants. J Pediatr 1975; 86: 395-398.
23. Tuladhar R, Davis PG, Batch J, Doyle LW. Establishment of a normal range of penile length in preterm infants. J Paediatr Child Health 1998; 35: 471-473.
24. Oberfeld SE, Mindok A, Shahrivar F, Klein JF, Levine LS. Clitoral size in full term infants. Am J Perinatol 1989; 6: 453-454.
25. Riley WJ, Rosenblaum AL. Clitoral size in infancy. J Pediatr 1980; 96: 918-919.
26. Philip M, De Boer C, Pilpel D, Karplus M, Sofer S. Clitoral and penile sizes of fullterm newborns in two different ethnic groups. J Pediatr Endocrinol Metab 1996; 9: 175-179.
27. Wolff PB, Wilbois RP, Weldon VV, Haymond MW. Posterior fusion without clitoromegaly in a female with partial 21 hydroxylase deficiency. J Pediatr 1977; 91: 951-952.
28. Callegari C, Everett S, Ross M, Brasel JA. Anogenital ratio: measure of virilisation in premature and fullterm newborn infants. J Pediatr 1987; 111: 240-243.
29. Reisner SH, Sivan Y, Nitzan M, Merlob P. Determination of anterior displacement of the anus in newborn infants and children. Pediatrics 1984; 73: 216-217.
30. Genc A, Taneli C, Tansug N, Kasirga E, Yilmaz D, Kucukoglu T, Onag A. Evaluation of the location of the anus by a modified technique in the neonate. J Pediatr Surg 2002; 37: 80-82.
31. Gassner I, Geley TE. Ultrasound of female genital anomalies. Eur Radiol 2004; 14: L107-L122 (epub ahead of print).
32. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS. Genotyping steroid 21 hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983; 57: 320-326.
33. Ahmed SF, Cheng A, Hughes IA. Assessment of the gonadotrophin-gonadal axis in androgen insensitivity syndrome. Arch Dis Child 1999; 80: 324-329.
34. Kolon TF, Miller OR. Comparison of single versus multiple dose regimens for the human chorionic gonadotropin stimulation test. J Urol 2001; 166: 1451-1454.
35. Cameron FJ, Montalto J, Byrt EA, Sinclair AH, Warne GL. Gonadal dysgenesis: associations between clinical features and sex of rearing. Endocr J 1997; 44: 95-104.
36. Rey RA, Belville C, Nihoul-Fekete C, Michel-Calemard L, Forest MG, Lahlou N, Jaubert F, Mowszowicz I, David M, Saka N, Bouvattier C, Bertrand AM, Lecointre C, Soskin S, Cabrol S, Crosnier H, Leger J, Lortat-Jacob S, Nicolino M, Rabl W, Toledo SP, Bas F, Gompel A, Czernichow P, Josso N. Evaluation of gonadal function in 107 intersex patients by means of serum antiMüllerian hormone measurement. J Clin Endocrinol Metab 1999; 84: 627-631.
37. Kubini K, Zachmann M, Albers N, Hiort O, Bettendorf M, Wolfle J, Bidlingmaier F, Klingmuller D. Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 2000; 85: 134-138.
38. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003; 349: 776-788.
39. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245-291. Erratum in Endocr Rev 2000; 21: 550.
40. New MI. Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol 2003; 211: 75-83.
41. Chang HL, Clark RD, Bachman H. The phenotype of 45,X/46,XY mosaicism: an analysis of 92 prenatally diagnosed cases. Am J Hum Genet 1990; 46: 156-167.
42. Slowikowska-Hilczer J, Romer TE, Kula K. Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype. J Androl 2003; 24: 270-278.
43. Warne GL, Hughes IA. The clinical management of ambiguous genitalia. In: Brooke CGD, ed. Clinical Paediatric Endocrinology, 3rd Ed. Oxford: Blackwell Science, 1995; 61-62.
44. Cameron FJ, Smith MJ, Warne GL, Sinclair AH. Novel mutation in the SRY gene results in gonadal dysgenesis. Hum Mutat 1998; Suppl 1: S110-111.
45. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, Gurakan B, Jameson JL. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose dependent manner. J Clin Endocrinol Metab 2002; 87: 1829-1833.
46. Ropke A, Pelz A-F, Volleth M Schlosser HW, Morlot S, Wieacker PF. Sex chromosome mosaicism in the gonads of patients with gonadal dysgenesis, but normal female or male karyotypes in lymphocytes. Am J Obst Gynecol 2004; 190: 1059-1062.
47. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 1995; 16: 271-321.
48. Boehmer AL, Brinkmann O, Bruggenwirth H, van Assendelft C, Otten BJ, Verleun-Mooijman MC, Niermeijer MF, Brunner HG, Rouwe CW, Waelkens JJ, Oostdijk W, Kleijer WJ, van der Kwast TH, de Vroede MA, Drop SL. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 2001; 86: 4151-4160.
49. Viner RM, Teoh Y, Williams DM, Patterson MN, Hughes IA. Androgen insensitivity syndrome: a survey of diagnostic procedures and management in the UK. Arch Dis Child 1997; 77: 305-309.
50. Ahmed SF, Cheng A, Dovey L Hawkins JR, Martin H, Rowland J, Shimura N, Tait AD, Hughes IA. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab 2000; 85: 658-665.
51. Melo KF, Mendonca BB, Billerbeck AE, Costa EM, Inacio M, Silva FA, Leal AM. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J Clin Endocrinol Metab 2003; 88: 3241-3250.
52. Simard J, Moisan AM, Michel LC, Morel Y. Males with 17β-hydroxysteroid dehydrogenase deficiency. Endocrinologist 2003; 13: 195-200.
53. Ulloa-Aguirre A, Bassol S, Poo J, Mendez JP, Mutchinick O, Robles C, Perez-Palacios G. Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17 ketosteroid reductase deficiency. J Clin Endocrinol Metab 1985; 60: 639-643.
54. Ahmed SF, Iqbal A, Hughes, IA. The testosterone: androstenedione ratio in male undermasculinisation. Clin Endocrinol 2000; 53: 697-702.
55. Boehmer AL, Brinkmann AO, Sandkuijl LA, Halley DJ, Niermeijer MF, Andersson S, de Jong FH, Kayserili H, de Vroede MA, Otten BJ, Rouwe CW, Mendonca BB, Rodrigues C, Bode HH, de Ruiter PE, Delemarre-van de Waal HA, Drop SL. 17β-Hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999; 84: 4713-4721.
56. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5 alpha reductase deficiency in man: an inherited form of pseudohermaphroditism. Science 1974; 86: 1213-1215.
57. Wilson JD, Griffin JE, Russell DW. Steroid 5α reductase 2 deficiency. Endocr Rev 1993; 14: 577-593.
58. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. Androgens and the evolution of male gender identity among male pseudohermaphrodites with 5 alpha reductase deficiency. N Engl J Med 1979; 300: 1233-1237.
59. Mendonca BB, Inacio M, Frade Costa EM, Arnhold IJ, Russell DW, Wilson JD. Male pseudohermaphroditism due to 5α reductase 2 deficiency: outcome of a Brazilian cohort. Endocrinologist 2003; 13: 201-204.
60. Krob G, Braun A, Kuhnle U. True hermaphroditism: worldwide incidence, chromosomal distribution, clinical findings, and gonadal histology. Eur J Pediatr 1994; 153: 2-10.
61. Amor D, Delatycki MB, Susman M, Casey E, Nash T, Warne G, Hutson J. 46,XX/46,XY at amniocentesis in a fetus with true hermaphroditism. J Med Genet 1999; 36: 866-869.
62. Berkovitz GD, Fechner PY, Marcantonio SM, Bland G, Stetten G, Goodfellow PN, Smith KD, Migeon CJ. The role of the sex determining region of the Y chromosome (SRY) in the aetiology of 46,XX true hermaphroditism. Hum Genet 1992; 88: 411-416.
63. Inoue H, Nomura M, Yanase T, Ichino I, Goto K, Ikuyama S, Takayanagi R, Nawata H. A rare case of 46,XX true hermaphroditism with hidden mosaicism with the sex determining region Y chromosome-bearing cells in the gonads. Intern Med 1998; 37: 467-471.
64. Queipo G, Zenteno JC, Pena R, Nieto K, Radillo A, Dorantes LM, Erana L, Lieberman E, Soderlund D, Jimenez AL, Ramon G, Kofman-Alfaro S. Molecular analysis in true hermaphroditism: demonstration of low level hidden mosaicism for Y-derived sequences in 46,XX cases. Hum Gen 2002; 111: 278-283.
65. Kuhnle U, Krob G, Maier E. True hermaphroditism: presentation, outcome and management. Endocrinologist 2003; 13: 214-218.
66. Josso N, Belville C, Picard J-Y. Mutations of AMH and its receptors. Endocrinologist 2003; 13: 247-251.
67. Plevraki E, Kita M, Goulis DG, Hatzisevastou-Loukidou H, Lambropoulos AF, Avramides A. Bilateral ovarian agenesis and the presence of the testis-specific protein 1-Y-linked gene: two new features of Mayer-Rokitansky-Kuster-Hauser syndrome. Fertil Steril 2004; 81: 689-692.
68. Morel Y, Rey R, Teinturier C, Nicolino M, Michel-Calemard L, Mowszowicz I, Jaubert F, Fellous M, Chaussain JL, Chatelain P, David M, Nihoul-Fekete C, Forest MG, Josso N. Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 2002; 161: 49-59.
69. Mendonca BB, Billebeck AEC, de Zegher F. Nongenetic male pseudohermaphroditism and reduced perinatal growth. N Engl J Med 2001; 345: 1135.
70. Warne GL. Congenital adrenal hyperplasia: long term outcome studies. Endocrinologist 2003; 13: 179-181.
71. Wisniewski AB, Migeon CJ, Meyer-Bahlburg HF, Berkowitz GD, Gearhart JP, Rock JA, Brown TR, Plotnick LP, Money J. Longterm outcome of patients with complete androgen insensitivity syndrome or congenital micropenis. Endocrinologist 2003; 13: 187-189.
72. Cheikhelard A, Luton D, Philippe-Chomette P, Leger J, Vuillard E, Garel C, Polak M, Nessmann C, Aigrain Y, El-Ghoneimi A. How accurate is the prenatal diagnosis of abnormal genitalia? J Urol 2000; 164: 984-987.
73. Chase C. What is the agenda of the Intersex Patient Advocacy Movement? Endocrinologist 2003; 13: 240-242.
74. Mendonca BB, Leite MV, de Castro M, Kino T, Elias LL, Bachega TA, Arnhold IJ, Chrousos GP, Latronico AC. Female pseudohermaphroditism caused by a novel missense mutation of the GR gene. J Clin Endocrinol Metab 2002; 87: 1805-1809.
75. Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 1991; 72: 560-566.
76. Kirk JM, Perry LA, Shand WS, Kirby RS, Besser GM, Savage MO. Female pseudo-hermaphroditism due to a maternal adrenocortical tumor. J Clin Endocrinol Metab 1990; 70: 1280-1284.
77. Vicens E, Martinez-Mora J, Potau N, Sans M, Boix-Ochoa. Masculinization of a female fetus by Krukenberg tumor during pregnancy. J Pediatr Surg 1980; 15: 188-190.
78. Grumbach MM, Ducharme JR, Molshok RE. On the fetal masculinising actions of certain oral progestins. J Clin Endocrinol Metab 1959; 19: 1369-1380.
79. Brunskill PJ. The effects of fetal exposure to danazol. Br J Obstet Gynecol 1992; 99: 212-214.
80. Kai H, Nose O, Iida Y, Ono J, Harada T, Yabuuchi H. Female pseudohermaphroditism caused by maternal congenital adrenal hyperplasia. J Pediatr 1979; 95: 418-420.
81. Mazza V, Di Monte I, Ceccarelli PL, Rivasi F, Falcinelli C, Forabosco A, Volpe A. Prenatal diagnosis of female pseudohermaphroditism associated with bilateral luteoma of pregnancy: case report. Hum Reprod 2002; 17: 821-824.
82. Tajima T, Fujieda K, Kouda N, Nakae J, Miller WL. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 2001; 86: 3820-3825.
83. Aarskog D. Maternal progestins as a possible cause of hypospadias. N Engl J Med 1979; 300: 75-78.
84. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am J Obstet Gynecol 1982; 142: 905-921.
85. Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CH. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 2004; 363: 2128-2135.